Washington Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.9M Sell
91,177
-1,277
-1% -$122K 0.27% 90
2025
Q4
$8.88M Sell
92,454
-1,294
-1% -$126K 0.29% 83
2025
Q3
$8.93M Buy
93,748
+2,178
+2% +$200K 0.29% 85
2025
Q2
$7.98M Sell
91,570
-574
-0.6% -$48.7K 0.28% 87
2025
Q1
$8.28M Sell
92,144
-2,291
-2% -$205K 0.32% 86
2024
Q4
$7.54M Sell
94,435
-649
-0.7% -$56.2K 0.27% 86
2024
Q3
$8.56M Sell
95,084
-1,537
-2% -$129K 0.3% 91
2024
Q2
$7.61M Sell
96,621
-1,685
-2% -$138K 0.28% 92
2024
Q1
$8.57M Buy
98,306
+348
+0.4% +$29.7K 0.31% 88
2023
Q4
$8.07M Sell
97,958
-968
-1% -$73.8K 0.32% 88
2023
Q3
$7.75M Buy
98,926
+250
+0.3% +$20.9K 0.34% 87
2023
Q2
$8.69M Buy
98,676
+1,192
+1% +$103K 0.37% 84
2023
Q1
$7.86M Buy
97,484
+2,805
+3% +$229K 0.35% 83
2022
Q4
$7.36M Sell
94,679
-24,096
-20% -$1.95M 0.34% 87
2022
Q3
$9.59M Buy
118,775
+263
+0.2% +$23.6K 0.48% 75
2022
Q2
$10.6M Buy
118,512
+2,972
+3% +$301K 0.5% 76
2022
Q1
$12.8M Buy
115,540
+10,853
+10% +$1.15M 0.51% 73
2021
Q4
$10.8M Buy
104,687
+1,607
+2% +$186K 0.41% 79
2021
Q3
$12.9M Sell
103,080
-76
-0.1% -$9.84K 0.36% 86
2021
Q2
$12.8M Buy
103,156
+6,681
+7% +$839K 0.36% 88
2021
Q1
$11.4M Buy
96,475
+574
+0.6% +$67.3K 0.35% 91
2020
Q4
$11.2M Buy
95,901
+2,168
+2% +$239K 0.36% 88
2020
Q3
$9.74M Buy
93,733
+1,475
+2% +$148K 0.36% 89
2020
Q2
$8.33M Sell
92,258
-14,824
-14% -$1.42M 0.35% 90
2020
Q1
$9.66M Buy
107,082
+673
+0.6% +$71.6K 0.46% 73
2019
Q4
$12.1M Buy
106,409
+638
+0.6% +$70K 0.48% 70
2019
Q3
$11.5M Buy
105,771
+393
+0.4% +$41K 0.62% 56
2019
Q2
$10.3M Buy
105,378
+2,344
+2% +$214K 0.56% 61
2019
Q1
$9.17M Sell
103,034
-528
-0.5% -$47.3K 0.51% 68
2018
Q4
$9.42M Sell
103,562
-330
-0.3% -$30.8K 0.6% 59
2018
Q3
$10.2M Sell
103,892
-4,338
-4% -$401K 0.55% 64
2018
Q2
$9.27M Buy
108,230
+11,233
+12% +$938K 0.5% 70
2018
Q1
$7.78M Sell
96,997
-1,173
-1% -$96.8K 0.46% 75
2017
Q4
$7.93M Sell
98,170
-240
-0.2% -$19.2K 0.45% 75
2017
Q3
$7.65M Buy
98,410
+1,054
+1% +$87.5K 0.46% 72
2017
Q2
$8.64M Buy
97,356
+62
+0.1% +$5.23K 0.53% 67
2017
Q1
$7.84M Buy
97,294
+3,729
+4% +$291K 0.5% 69
2016
Q4
$6.66M Sell
93,565
-1,138
-1% -$89.4K 0.43% 80
2016
Q3
$8.18M Buy
94,703
+1,938
+2% +$169K 0.54% 67
2016
Q2
$8.05M Sell
92,765
-259
-0.3% -$20.9K 0.54% 64
2016
Q1
$6.98M Buy
93,024
+2,958
+3% +$223K 0.47% 70
2015
Q4
$6.93M Sell
90,066
-62
-0.1% -$4.67K 0.47% 71
2015
Q3
$6.03M Buy
90,128
+258
+0.3% +$19K 0.44% 74
2015
Q2
$6.66M Buy
89,870
+3,932
+5% +$300K 0.44% 74
2015
Q1
$6.7M Buy
85,938
+75,459
+720% +$5.72M 0.44% 78
2014
Q4
$757K Buy
10,479
+173
+2% +$12K 0.05% 131
2014
Q3
$639K Hold
10,306
0.05% 134
2014
Q2
$657K Buy
10,306
+400
+4% +$24.3K 0.05% 131
2014
Q1
$609K Hold
9,906
0.05% 131
2013
Q4
$569K Sell
9,906
-10
-0.1% -$567 0.04% 139
2013
Q3
$528K Hold
9,916
0.04% 139
2013
Q2
$510K Buy
+9,916
New +$490K 0.04% 136

Other funds holding MDT

Washington Trust's MDT Position: Q1 2026 in Review

Washington Trust reduced its Medtronic (MDT) stake by 1.4% in Q1 2026, selling an estimated $122K and leaving 91,177 shares worth $7.9M. The position accounts for 0.27% of the portfolio, ranked #90.

Washington Trust first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.9M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Washington Trust held 91,177 shares of Medtronic worth $7.9M as of Q1 2026.
  • Washington Trust sold 1,277 Medtronic shares in Q1 2026, an estimated $122K.
  • Medtronic made up 0.27% of Washington Trust's portfolio in Q1 2026, its #90 holding.
  • Washington Trust first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Washington Trust's Medtronic position peaked at $12.9M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Washington Trust's 13F filing for Q1 2026, filed 6 Apr 2026.